JORDAN WEAVER: Open Payments
NPI 1780121863 · MUSCLE SHOALS, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,557 in 80 payments from 37 companies in 2025. Trend: 2023 $1,004 · 2024 $760 · 2025 $1,557
Food & beverage: $1,382Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $244 |
| AstraZeneca Pharmaceuticals LP | 13 | $220 |
| Amgen Inc. | 1 | $175 |
| Corcept Therapeutics | 4 | $68 |
| Phathom Pharmaceuticals, Inc. | 3 | $56 |
| PFIZER INC. | 3 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| Janssen Biotech, Inc. | 2 | $39 |
| BeOne Medicines USA, Inc. | 2 | $35 |
| Eisai Inc. | 2 | $35 |
Products named: PROLIA, Ozempic, FARXIGA, Wegovy, Korlym, VOQUEZNA, BREZTRI, Nubeqa.
Industry payments across AL — which companies pay providers there.
